News
Innovations in cell-free gene synthesis decrease turnaround times for obtaining full-length, complex, NGS-verified DNA from weeks or months to as few as 6-8 business days. Cell-free DNA speeds ...
Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...
(Graphic: Business Wire) Alchemy cell-free DNA technology is now available at research grade, providing researchers with a faster, more efficient method to produce high-quality DNA templates.
For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...
A new blood test utilizing cell-free DNA from the placenta can predict preterm preeclampsia with 80% accuracy. This condition, causing significant maternal and fetal mortality, has been difficult ...
Cell-Free Fetal DNA Testing MarketThe global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million ...
A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in most people confirmed to have the ...
Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...
Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that permits early diagnosis of antibody-mediated rejection (AMR) in kidney transplant recipients with de novo anti-HLA donor ...
When genes are more active, key regions are nucleosome-free – which allows easier access of TFs to the DNA. Dr. MacPherson further explained that, meanwhile, “for a gene that's highly expressed, ...
Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results